OPEN APP
Home >Companies >News >Datar Genetics partners Apollo Hospitals for precision oncology
Photo: HT
Photo: HT

Datar Genetics partners Apollo Hospitals for precision oncology

The partnership integrates molecular and genetic analysis with the diagnosis, treatment and monitoring of cancers

Hyderabad: Datar Genetics Ltd has joined hands with Apollo Hospitals to provide precision oncology, a cancer management technique which brings down pain and lowers costs.

The partnership integrates molecular and genetic analysis with the diagnosis, treatment and monitoring of cancers and also explores precision matching for organ and bone marrow transplants.

Datar, in a statement, said it has developed technologies for non-invasive liquid biopsies, in vitro chemo-sensitivity assessment and ultra-high resolution gene expression-based therapy with low pain.

“Precision diagnosis gives patients the best chance to fight cancer upfront, save costs, reduce suffering and reduce time to productivity," said K. Hariprasad, president, Apollo Hospitals.

Subscribe to Mint Newsletters
* Enter a valid email
* Thank you for subscribing to our newsletter.

Click here to read the Mint ePaperMint is now on Telegram. Join Mint channel in your Telegram and stay updated with the latest business news.

Close
×
Edit Profile
My Reads Redeem a Gift Card Logout